Educational Objectives:
 |
Examine the benefits to patients with chronic kidney disease (CKD) of a team approach to the managment of mineral and bone disease.
|
|
Identify strategies for treatment of mineral and bone disease in patients with CKD
|
|
Summarize new developments and future practices related to improving mortality and clinical outcomes in all patients with CKD
|
|
Craig B. Langman, MD
Professor of Kidney Diseases,
Feinberg School of Medicine,
Northwestern University
Kim Alleman, MS, RN, FNP-BC, CNN
Nurse Practitioner
Hartford Hospital Transplant Program
|
|
 |
This activity
has been planned and produced in accordance with
CE guidelines and policies. From a CE symposium
held in September 2008 at the American Nephrology
Nurses' Association (ANNA) Fall Symposium in Chicago, IL.
This activity provides 1.25 contact hours.
The American Nephrology Nurses’ Association (ANNA) is accredited as a provider
of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is a Provider approved by the California Board of Registered Nursing, provider number CEP 00910 for 1.25 contact hours.
|
 |
Posting Date: January 12, 2009
CE Credit Eligible
Through: January 12, 2011
CE Credit Hours/Completion Time: 1.25
Target Audiences: Nephrology nurses and technicians.
Method of participation: Listen to the talk, read the PubMed
abstracts linked to data slides and talk references, take the post-test, read
the linked abstracts in the post-test answer feedback material. |
 |
| SPEAKER DISCLOSURE STATEMENT: |
See individual talks.
This ANNA Satellite symposium was developed by ANNA and sponsored by an educational grant from Genzyme Pharmaceuticals.
| ANNA and HDCN CE POLICY
STATEMENTS: |
The CE policy and disclosure statements of the American Nephrology Nurses' Association
are given in detail on the Symposium
Home Page. The CE policy statements of HDCN are
listed on this page. |
|
